- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01169441
Lead Extract Study (EXTRACT)
July 23, 2010 updated by: St. Paul Heart Clinic
EXTRACT Study (Data Collection on the Extraction of 2nd and 3rd Generation Defibrillation Leads)
The recent expansion of indications for implantable cardioverter defibrillators (ICDs) has changed the population of patients being implanted.
Younger and healthier patients are now being implanted for primary prevention of sudden cardiac death.
Due to the younger population, the likelihood of the lead failing during the lifetime of the patient is higher and also more likely to need extraction.
To reduce the risk of the lead extraction procedure and therefore reduce the number of abandon leads, ICD lead manufacturers are designing leads to offer improved chronic extractability to reduce the morbidity and mortality during these procedures.
Study Overview
Status
Completed
Conditions
Detailed Description
This study will enroll up to 100 subjects at our site only.
Prior to the procedure information will be collected including the subjects demographics, medications, medical, cardiovascular and surgical history.
During the lead extraction procedure specific data will be gathered which includes items such as: total lead length, lead length from insertion site to connector end of lead just prior to lead extraction, extraction tools used and the physician description of the extraction.
The patients will undergo an assessment of extraction force up to 3 kilograms maximum to the ICD lead for a specified amount of time before the use of laser or extraction sheaths.
Extraction forces and approximate times will be monitored and recorded throughout the procedure.
Forces will be measured by using a force gauge.
Xrays will be taken to show lead position during movement of the arm at the side, above the head and across the chest.
Fluoroscopy images of the heart may be saved.
The amount of extra time added to the case in order to perform this study and collect the data is estimated at 10 minutes.
Participation in the study is complete following the procedure.
There is a 30-day follow-up phone call to capture any adverse events which require a clinic visit, ER visit or hospitalization.
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
St. Paul, Minnesota, United States, 55102
- St. Paul Heart Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects who are scheduled for an ICD lead extraction
Description
Inclusion Criteria:
- Subjects must be 18 years of age or older,
- be scheduled for an ICD lead extraction and
- willing and able to sign the informed consent.
Exclusion Criteria:
- Patients with lead implant duration less than 6 months,
- patients with gross chronic lead infections,
- patients with epicardial or subcutaneous ICD systems (without transvenous ICD lead) and
- patients who are pregnant or suspect they may be pregnant.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Pierce J. Vatterott, M.D., St. Paul Heart Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2006
Primary Completion (Actual)
March 1, 2010
Study Completion (Actual)
May 1, 2010
Study Registration Dates
First Submitted
May 28, 2009
First Submitted That Met QC Criteria
July 23, 2010
First Posted (Estimate)
July 26, 2010
Study Record Updates
Last Update Posted (Estimate)
July 26, 2010
Last Update Submitted That Met QC Criteria
July 23, 2010
Last Verified
May 1, 2009
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- #2265-4
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Surgical Procedures
-
Samsung Medical CenterCompletedSternotomy | Cardiac Surgical Procedures | Thoracic Surgical ProceduresKorea, Republic of
-
Dr. Hamdy SingabRecruitingCardiac Surgical ProceduresEgypt
-
Wuhan Union Hospital, ChinaCompletedCardiac Surgical ProceduresChina
-
University of Sao Paulo General HospitalHospital Israelita Albert Einstein; Instituto Dante Pazzanese de Cardiologia; Beneficência Portuguesa de São Paulo and other collaboratorsCompletedCardiac Surgical ProceduresBrazil
-
Nationwide Children's HospitalCompleted
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
Wuhan Union Hospital, ChinaRecruitingCardiac Surgical ProceduresChina
-
Clinique du MillenaireNot yet recruitingCardiac Surgical Procedures
-
Fundació Institut de Recerca de l'Hospital de la...Completed
-
Lawson Health Research InstituteWestern University, CanadaCompletedCardiac Surgical Procedures